Fig 1.
Simplified decision-analytical model for PPH prevention with carbetocin versus oxytocin.
PPH: Postpartum hemorrhage.
Table 1.
Model input parameters.
Table 2.
Base-case analysis.
Fig 2.
Two-way sensitivity analysis of relative risk of PPH ≥500 mL with carbetocin and proportion of child births by Caesarean section on cost-effectiveness of carbetocin.
Threshold line divided the grey zone and white zone; combinations of variables on threshold line had the same cost-effectiveness for carbetocin and oxytocin; white zone: combinations of variables leaded to oxytocin to be cost-effective; grey zone: combinations of variables leaded to carbetocin to be cost-effective. PPH: Postpartum haemorrhage.
Fig 3.
Scatter plot of the incremental cost against QALY saved by the carbetocin group versus the oxytocin group in 10,000 Monte Carlo simulations.
QALY: quality-adjusted life-year.